OM (STOCKS)
Outset Medical, Inc. Common Stock
$4.310000
-0.180000 (-4.01%)
Prev close: $4.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Leslie L. Trigg
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $79.90M
- Employees
- 354
- P/E (TTM)
- -1.08
- P/B (TTM)
- 0.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.83 | $-0.81 | -0.0163 | -2.00% |
|
Dec 2025 (Q4)
|
$-0.84 | $-0.66 | -0.1834 | -27.93% |
|
Sep 2025 (Q3)
|
$-0.69 | $-0.67 | -0.0153 | -2.27% |
|
Jun 2025 (Q2)
|
$-0.84 | $-1.01 | +0.1720 | +17.00% |
Financial Statements
| Revenues | $117.59M |
| Benefits Costs and Expenses | $191.62M |
| Cost Of Revenue | $69.80M |
| Costs And Expenses | $191.62M |
| Gross Profit | $47.78M |
| Nonoperating Income/Loss | $6.96M |
| Operating Expenses | $115.01M |
| Research and Development | $21.34M |
| Other Operating Expenses | $89.37M |
| Operating Income/Loss | -$67.23M |
| Income/Loss From Continuing Operations After Tax | -$74.85M |
| Income/Loss From Continuing Operations Before Tax | -$74.03M |
| Income Tax Expense/Benefit | $820.00K |
| Interest Expense, Operating | $13.76M |
| Net Income/Loss | -$74.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$74.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$74.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.07 |
| Diluted Earnings Per Share | -$4.07 |
| Basic Average Shares | 54,882 |
| Diluted Average Shares | 54,882 |
| Assets | $249.45M |
| Current Assets | $236.71M |
| Inventory | $49.65M |
| Other Current Assets | $187.06M |
| Noncurrent Assets | $12.75M |
| Fixed Assets | $4.07M |
| Other Non-current Assets | $8.67M |
| Liabilities | $137.77M |
| Current Liabilities | $37.61M |
| Accounts Payable | $1.44M |
| Other Current Liabilities | $36.17M |
| Noncurrent Liabilities | $100.16M |
| Equity | $111.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $111.69M |
| Liabilities And Equity | $249.45M |
| Net Cash Flow From Operating Activities | -$33.51M |
| Net Cash Flow From Operating Activities, Continuing | -$33.51M |
| Net Cash Flow From Investing Activities | -$11.71M |
| Net Cash Flow From Investing Activities, Continuing | -$11.71M |
| Net Cash Flow From Financing Activities | $348.00K |
| Net Cash Flow From Financing Activities, Continuing | $348.00K |
| Net Cash Flow | -$44.87M |
| Net Cash Flow, Continuing | -$44.87M |
| Comprehensive Income/Loss | -$74.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.01M |
| Other Comprehensive Income/Loss | -$56.43M |